We are international
Donate
• about myeloma TEXT SIZE   
the understanding series    back

ASH 2011: Dr. Jakubowiak - Final Results of a Frontline Phase 1/2 Study of Carfilzomib, Lenalidomide, and Low-Dose Dexamethasone (CRd) in Multiple Myeloma (MM)
Andrzej J Jakubowiak, MD, PhD
University of Michigan
Ann Arbor, Michigan, USA
12.06.11


To view the video full screen, click on the small button next to the volume control in the lower right hand corner.


 related articles